Home › Multipel myeloom › Michigan › Ann Arbor
Multipel myeloom klinische studies in Ann Arbor, MI
10 studies voor Multipel myeloom zoeken deelnemers op locaties in en rond Ann Arbor (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 2
- University of Michigan Health System, Ann Arbor
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruterenFase 3
- University of Michigan, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruterenFase 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruterenFase 1/2
- Research Site, Ann Arbor
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekruterenFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mijl verwijderd
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mijl verwijderd
- en nog 4
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekruterenFase 1/2
- Research Site, Ann Arbor
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
RekruterenFase 4
- University of Michigan, Ann Arbor
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruterenFase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mijl verwijderd
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mijl verwijderd
- en nog 4
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruterenFase 3
- GSK Investigational Site, Ann Arbor
Multipel myeloom studies in andere steden
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Andere studies in Ann Arbor
- Prostaatkanker27 studies
- Borstkanker26 studies
- Niet-kleincellige longkanker26 studies
- Kanker (alle vormen)25 studies
- Colorectale kanker23 studies
- Longkanker23 studies
- Hartfalen22 studies
- Acute myeloïde leukemie17 studies
- Cardiovasculaire ziekte16 studies
- Aldermeesklierkanker14 studies
- Melanoom12 studies
- Nierkanker (niercelcarcinoom)12 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.